Rate of decline in progressive supranuclear palsy.

Rate of decline in progressive supranuclear palsy.

Item
http://www.wikidata.org/entity/Q39234422
Key emerging issues in progressive supranuclear palsy and corticobasal degenerationThe evolution of primary progressive apraxia of speech.Sample size calculations for clinical trials targeting tauopathies: a new potential disease targetFinding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsyPower calculations and placebo effect for future clinical trials in progressive supranuclear palsy.PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate.Looking for Measures of Disease Severity in the Frontotemporal Dementia Continuum.Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
P2860

Rate of decline in progressive supranuclear palsy.

Item
http://www.wikidata.org/entity/Q39234422
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rate of decline in progressive supranuclear palsy.
@en
Rate of decline in progressive supranuclear palsy.
@nl
type
label
Rate of decline in progressive supranuclear palsy.
@en
Rate of decline in progressive supranuclear palsy.
@nl
prefLabel
Rate of decline in progressive supranuclear palsy.
@en
Rate of decline in progressive supranuclear palsy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Rate of decline in progressive supranuclear palsy.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698